Patient Who Wouldn't Be Here Without Axcan's Photofrin Should Disappear Now, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Web videos featuring overblown patient testimonials prove an easy target for DDMAC.
You may also be interested in...
DDMAC Numb To Purported Advantages Of Dental Anesthetic
Warning letter continues FDA's trend of citing superiority claims based on the route of administration.
DDMAC Numb To Purported Advantages Of Dental Anesthetic
Warning letter continues FDA's trend of citing superiority claims based on the route of administration.
Luvox CR Symptom Benefit Claims Draw DDMAC Warning
An FDA warning letter to Jazz Pharmaceuticals citing a Luvox CR (fluvoxamine maleate) patient brochure continues an agency trend of targeting efficacy claims about individual symptoms of a broader disease state